Diagnosis and Management of Facial Hypopigmented Lesions in Infants
Differential Diagnosis
- Pityriasis alba presents as ill‑defined, scaly hypopigmented patches on the cheeks and perioral area and is strongly associated with atopic diathesis and dry skin. 1
- Vitiligo appears as well‑demarcated, chalk‑white depigmented patches with a periorificial distribution (mouth, eyes, other orifices). 2
- Peutz‑Jeghers syndrome can manifest in infancy with dark brown or blue‑brown macules on the vermilion border of the lips and buccal mucosa and is linked to gastrointestinal hamartomatous polyps. [3][4]
Clinical Work‑up
- Wood’s lamp examination accentuates the hypopigmentation of pityriasis alba (no fluorescence) and clearly delineates the complete depigmentation of vitiligo. [2][1]
- Assessment for atopic features (e.g., xerosis, eczema) supports a diagnosis of pityriasis alba. 1
- Thyroid evaluation (function tests and autoantibodies) is recommended when vitiligo is suspected because autoimmune thyroid disease occurs in ~34 % of affected children. 5
- Dermatology referral is advised for atypical presentations or diagnostic uncertainty. [2][1]
First‑Line Management
Pityriasis Alba (most likely diagnosis)
- Emollients and moisturizers to correct underlying dry skin and atopic features. 1
- Mild‑to‑moderate potency topical corticosteroids for a limited period to avoid skin atrophy. 1
- Potent topical steroids may be used but should not exceed a 2‑month trial because of atrophy risk. 1
- Topical calcineurin inhibitors (pimecrolimus or tacrolimus) are a safer alternative for facial skin with a favorable short‑term safety profile. [2][1]
Vitiligo (if diagnosed)
- Potent or very potent topical corticosteroids for no longer than 2 months in children < 18 years. 2
- Topical calcineurin inhibitors preferred over highly potent steroids for facial application due to better safety. 2
- Thyroid screening because of the 34 % prevalence of autoimmune thyroid disease in this population. 5
- Psychological support for the child and family given the significant quality‑of‑life impact. [2][5]
Associated Conditions
| Condition | Typical Skin Findings | Systemic Association | Key Reference |
|---|---|---|---|
| Peutz‑Jeghers syndrome | Dark brown/blue‑brown macules on lip vermilion and buccal mucosa (infancy) | Gastrointestinal hamartomatous polyps | [3][4] |
Common Pitfalls to Avoid
- Prolonged use of potent steroids (> 2 months) leads to facial skin atrophy. [2][1]
- Omitting thyroid screening in vitiligo patients misses treatable autoimmune disease present in one‑third of cases. 5
- Confusing hypopigmentation with depigmentation: pityriasis alba shows partial pigment loss; vitiligo shows complete loss. 2
- Overlooking atopic features delays appropriate treatment of pityriasis alba. 1
- Neglecting psychological impact of visible facial lesions on children and families. [2][5]